Xcenda's PRO Thought Leader Featured in The American Journal of Managed Care

October 19, 2018

Xcenda's thought leader for patient-reported outcomes, Somali Misra Burgess, PhD, provides insights to a recent article in The American Journal of Managed Care® (AJMC®). The article titled, What's Preventing Widespread Use of Patient-Reported Outcomes in Drug Development? looks at the current challenges facing stakeholders in adopting more PRO measures for coverage decisions. 

What's Preventing Widespread Use of Patient-Reported Outcomes in Drug Development?

Xcenda's thought leader on patient-reported outcomes (PROs), Somali Misra Burgess, PhD, spoke with Jaime Rosenberg from the American Journal of Managed Care® (AJMC®) to provide insights on the variety of challenges facing stakeholder when considering PROs. 

 

“While there is a push to include PRO measures as end points in phase 3 clinical trials for drug approval, integration has been slow.”

Somali Burgess, PhD, senior director, Xcenda